Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$573K Sell
1,360
-227
-14% -$90.5K 0.24% 65
2026
Q2
$575K Sell
1,587
-118
-7% -$40.4K 0.26% 60
2026
Q1
$600K Buy
1,705
+108
+7% +$38.5K 0.34% 58
2025
Q4
$523K Buy
+1,597
New +$507K 0.32% 84

Other funds holding AMGN

EJMK Ventures's AMGN Position: Q3 2026 in Review

EJMK Ventures reduced its Amgen (AMGN) stake by 14% in Q3 2026, selling an estimated $90.5K and leaving 1,360 shares worth $573K. The position accounts for 0.24% of the portfolio, ranked #65.

EJMK Ventures first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $600K in Q1 2026. 3,263 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • EJMK Ventures held 1,360 shares of Amgen worth $573K as of Q3 2026.
  • EJMK Ventures sold 227 Amgen shares in Q3 2026, an estimated $90.5K.
  • Amgen made up 0.24% of EJMK Ventures's portfolio in Q3 2026, its #65 holding.
  • EJMK Ventures first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • EJMK Ventures's Amgen position peaked at $600K in Q1 2026.
  • 3,263 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.